Bobby Chacko
Impact in
- Nephrology top 2%
- Renal Diseases and Glomerulopathies
- Chronic Kidney Disease and Diabetes
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
Papers in ⓘ
- Nephrology 20
- Renal Diseases and Glomerulopathies 12
- Chronic Kidney Disease and Diabetes 4
- Dialysis and Renal Disease Management 4
- Acute Kidney Injury Research 3
- Co-authors
- George John (6 shared papers)M.G. Kirubakaran (3 shared papers)C. K. Jacob (3 shared papers)Anila Korula (3 shared papers)Tom Lea‐Henry (3 shared papers)Nithya Neelakantan (3 shared papers)Mohit Mathur (4 shared papers)Tak Mao Chan (2 shared papers)
- Journals
- Nephrology (5 papers)Renal Failure (2 papers)Flora (2 papers)Clinical Nephrology (1 paper)Journal of Renal Care (1 paper)
- Partner nations
- AustraliaIndiaUnited States
In The Last Decade
Bobby Chacko
29 papers receiving 533 citations
Hit Papers
Peers
Comparison fields: 5 of 77
- Nephrology 296
- Transplantation 54
- Hematology 76
- Pathology and Forensic Medicine 92
- Rheumatology 69
Countries citing papers authored by Bobby Chacko
This map shows the geographic impact of Bobby Chacko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bobby Chacko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bobby Chacko more than expected).
Fields of papers citing papers by Bobby Chacko
This network shows the impact of papers produced by Bobby Chacko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bobby Chacko. The network helps show where Bobby Chacko may publish in the future.
Co-authors
The 25 scholars most cited alongside Bobby Chacko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy Hit paper breakdown → | 2023 | 100 |
| 2 | 2006 | 89 | |
| 3 | 2011 | 44 | |
| 4 | 2007 | 40 | |
| 5 | 2019 | 35 | |
| 6 | 2005 | 31 | |
| 7 | 2006 | 26 | |
| 8 | 2018 | 25 | |
| 9 | 2014 | 23 | |
| 10 | 2007 | 21 | |
| 11 | 2017 | 21 | |
| 12 | 2018 | 17 | |
| 13 | 2018 | 14 | |
| 14 | 2007 | 11 | |
| 15 | 2005 | 9 | |
| 16 | 1991 | 9 | |
| 17 | 2011 | 8 | |
| 18 | 2023 | 8 | |
| 19 | 2007 | 6 | |
| 20 | 2017 | 5 |
About Bobby Chacko
Bobby Chacko is a scholar working on Nephrology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Hematology and Public Health, Environmental and Occupational Health, having authored 41 papers that have together received 562 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (12 papers), Chronic Kidney Disease and Diabetes (4 papers), Platelet Disorders and Treatments (4 papers), Dialysis and Renal Disease Management (4 papers), Acute Kidney Injury Research (3 papers), Renal Transplantation Outcomes and Treatments (3 papers), Cytomegalovirus and herpesvirus research (3 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). The work is most often cited by research in Nephrology (296 citations), Transplantation (54 citations), Hematology (76 citations), Pathology and Forensic Medicine (92 citations) and Rheumatology (69 citations). Bobby Chacko has collaborated with scholars based in Australia, India and United States. Frequent co-authors include George John, M.G. Kirubakaran, C. K. Jacob, Anila Korula, Tom Lea‐Henry, Nithya Neelakantan, Mohit Mathur, Tak Mao Chan, Kook‐Hwan Oh and Laura Kooienga. Their work appears in journals such as Nephrology, Renal Failure, Flora, Clinical Nephrology and Journal of Renal Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.